Acute toxic effects of club drugs (Q34370377)

1 August 2017

1 reference

title

Acute toxic effects of club drugs (English)

1 reference

1 August 2017

Robert S Gable

1

1 reference

1 August 2017

1 September 2004

1 reference

Journal of Psychoactive Drugs

1 August 2017

1 reference

1 August 2017

36

1 reference

1 August 2017

303-313

1 reference

1 August 2017

3

1 reference

Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat.

1 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Clinical course of gamma-hydroxybutyrate overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Illicit use of ketamine in Scotland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Acute toxicity and gross behavioral effects of amphetamine, four methoxyamphetamines, and mescaline in rodents, dogs, and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Distribution study of 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine in a fatal overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Flunitrazepam: an evaluation of use, abuse and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Sudden death and benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Deaths Involving the Benzodiazepine Flunitrazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Near-fatal gamma-butyrolactone intoxication--first report in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Prevalence of drugs used in cases of alleged sexual assault

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Potentiation of lethality and increase in body temperature by combined use of d-methamphetamine and morphine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

The health effects of ecstasy: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Inadvertent ketamine overdose in children: clinical manifestations and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

A method of conducting therapeutic sessions with MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

The psychotropic effect of ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

MDMA misrepresentation: an unresolved problem for Ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Coma and respiratory depression following the ingestion of GHB and its precursors: three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Ketamine and military anaesthesia. The effect of heavy papaveretum premedication and Althesin induction on the incidence of emergence phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

A review of the nonmedical use of ketamine: use, users and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

The nonmedical use of ketamine, part two: A review of problem use and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

GHB. Club drug or confusing artifact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

21 January 2018

Sodium 4-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Sexual assault under benzodiazepine submission in a Paris suburb

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Trends in illicit drug emergencies: the emerging role of gamma-hydroxybutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

High rates of midazolam self-administration in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

GHB: a new and novel drug of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Tissue distribution of ketamine: two case reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Ethanol potentiates the toxic effects of 1,4-butanediol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Retracted article on dopaminergic neurotoxicity of MDMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

A review of disorders of water homeostasis in psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Gamma hydroxybutyrate overdose: two cases illustrate the unique aspects of this dangerous recreational drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Body packing presenting as sudden collapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Serum and urine concentrations of flunitrazepam and metabolites, after a single oral dose, by immunoassay and GC-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Cigarette smoking and cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Toxicological interactions between alcohol and benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

A comprehensive review of MDMA and GHB: two common club drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Sites of action of gamma-hydroxybutyrate (GHB)--a neuroactive drug with abuse potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

An "accidental" acute psychosis with ecstasy use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Persistent psychosis after a single ingestion of 'ecstasy'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Acute Psychological and Neurophysiological Effects of MDMA in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Ketamine abusers presenting to the emergency department: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

Adverse events, including death, associated with the use of 1,4-butanediol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2004.10400031

10.1080/02791072.2004.10400031

21 January 2018

Identifiers

DOI

1 reference

release_khcq75t35veejfhxpgpmuwgchi

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/khcq75t35veejfhxpgpmuwgchi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15559678

1 reference

PubMed ID

15559678